ePrints

Pyrrolcarboxamide Derivatives for the Inhibition of ERK5

Lookup NU author(s): Tristan Reuillon, Duncan MillerORCiD, Stephanie Myers, Dr Lauren Molyneux, Dr Celine CanoORCiD, Dr Ian HardcastleORCiD, Professor Roger Griffin, Dr Laurent Rigoreau, Emeritus Professor Bernard Golding, Professor Martin NobleORCiD

Downloads

Full text is not currently available for this publication.

Abstract

The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5, in particular cancers

Publication metadata

Inventor(s): Reuillon T, Miller D, Myers S, Molyneux L, Cano C, Hardcastle I, Griffin R, Rigoreau L, Golding B, Noble M

Publication type: Patent

Publication status: Published

Year: 2016

Print publication date: 24/03/2016

Acceptance date: 24/03/2016

Share